Pub Date : 2026-12-01Epub Date: 2026-08-24DOI: 10.1002/ijc.70696
{"title":"Correction to \"Health-Related Quality of Life in Chinese Children and Adolescents With Cancer: A Systematic Review and Meta-Analysis\".","authors":"","doi":"10.1002/ijc.70696","DOIUrl":"10.1002/ijc.70696","url":null,"abstract":"","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":" ","pages":"2850"},"PeriodicalIF":4.9,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148808039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Reply to: Comments on \"Survival by Detection Pathway in Patients With Lung Cancer-A Nationwide Descriptive Epidemiological Study in Japan\".","authors":"Ryo Koto, Atsuki Yamamoto, Ikumi Takashima, Chikako Iwao, Jung-Ho Shin, Yuko Hayashi, Hiroshi Kitagawa, Yoshiharu Horie","doi":"10.1002/ijc.70678","DOIUrl":"10.1002/ijc.70678","url":null,"abstract":"","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":" ","pages":"2621-2622"},"PeriodicalIF":4.9,"publicationDate":"2026-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148672843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-11-15Epub Date: 2026-08-05DOI: 10.1002/ijc.70677
Masashi Matsuzaka, Rina Tanaka
{"title":"Comments on 'Survival by Detection Pathway in Patients With Lung Cancer: A Nationwide Descriptive Epidemiological Study in Japan'.","authors":"Masashi Matsuzaka, Rina Tanaka","doi":"10.1002/ijc.70677","DOIUrl":"10.1002/ijc.70677","url":null,"abstract":"","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":" ","pages":"2619-2620"},"PeriodicalIF":4.9,"publicationDate":"2026-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148672808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-11-15Epub Date: 2026-07-10DOI: 10.1002/ijc.70646
Youmi Shin, Dong Keon Kim, Yoojeong Seo, Hyeon Hee Lee, Jihye Park, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Jongwon Oh, Sanghoo Lee, Tae Il Kim
Lynch syndrome (LS) is a hereditary cancer predisposition syndrome caused by germline mutation of DNA mismatch repair (MMR) genes, most notably associated with colorectal cancer. Although LS patients face high risk of CRC, risk can vary even among those with the same pathogenic MMR germline mutations. We suggest a functional assay platform for assessing mutation risk using patient-derived organoid (PDOs). We measured organoid response to the cytotoxic effects of a methylating agent, N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) based on DNA damage-induced apoptosis. When normal (non-LS) colon organoids were used, treatment with MNNG and four passages of organoid culture led to decreased total growth (organoid area), but there was no significant change in number. To increase the effect of MNNG and induce apoptosis in normal colon organoids, we added O6BG (an MGMT inhibitor) and an ATR inhibitor. The cytotoxic effects of combined treatment with MNNG, O6BG and ATR inhibitor on non-LS-PDOs were significantly higher than in PDOs of LS patients. To detect the difference at an earlier phase, we examined DNA damage response by analyzing γH2AX expression after treatment with MNNG and O6BG for 24 h. Then, we found higher expression of γH2AX in non-LS-PDOs than in PDOs of LS patients, suggesting continued cell survival with mutation accumulation in LS-PDOs. In conclusion, treatment with MNNG and O6BG using PDOs and measurement of resulting DNA damage response could be used as a preclinical platform for risk stratification in LS patients.
{"title":"Evaluation of Mutation Risk Using Patient-Derived Organoids in Patients With Lynch Syndrome.","authors":"Youmi Shin, Dong Keon Kim, Yoojeong Seo, Hyeon Hee Lee, Jihye Park, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Jongwon Oh, Sanghoo Lee, Tae Il Kim","doi":"10.1002/ijc.70646","DOIUrl":"10.1002/ijc.70646","url":null,"abstract":"<p><p>Lynch syndrome (LS) is a hereditary cancer predisposition syndrome caused by germline mutation of DNA mismatch repair (MMR) genes, most notably associated with colorectal cancer. Although LS patients face high risk of CRC, risk can vary even among those with the same pathogenic MMR germline mutations. We suggest a functional assay platform for assessing mutation risk using patient-derived organoid (PDOs). We measured organoid response to the cytotoxic effects of a methylating agent, N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) based on DNA damage-induced apoptosis. When normal (non-LS) colon organoids were used, treatment with MNNG and four passages of organoid culture led to decreased total growth (organoid area), but there was no significant change in number. To increase the effect of MNNG and induce apoptosis in normal colon organoids, we added O<sup>6</sup>BG (an MGMT inhibitor) and an ATR inhibitor. The cytotoxic effects of combined treatment with MNNG, O<sup>6</sup>BG and ATR inhibitor on non-LS-PDOs were significantly higher than in PDOs of LS patients. To detect the difference at an earlier phase, we examined DNA damage response by analyzing γH2AX expression after treatment with MNNG and O6BG for 24 h. Then, we found higher expression of γH2AX in non-LS-PDOs than in PDOs of LS patients, suggesting continued cell survival with mutation accumulation in LS-PDOs. In conclusion, treatment with MNNG and O6BG using PDOs and measurement of resulting DNA damage response could be used as a preclinical platform for risk stratification in LS patients.</p>","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":" ","pages":"2585-2594"},"PeriodicalIF":4.9,"publicationDate":"2026-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13595499/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148417193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-11-15Epub Date: 2026-07-02DOI: 10.1002/ijc.70634
Tillmann Bedau, Thomas Zander, Hans Anton Schlößer, Hakan Alakus, Onur Mustafov, Reinhard Büttner, Christiane Bruns, Alexander Quaas
MET is an actionable receptor tyrosine kinase, and MET-directed antibody-drug conjugates (ADCs) have recently entered clinical practice with FDA approval in non-small cell lung cancer and are now being evaluated across gastrointestinal malignancies, with patient selection based on MET immunohistochemistry (IHC) 3+ membranous staining at varying percentage thresholds. However, robust real-world data on MET protein expression and clinically relevant ADC-aligned thresholds in upper GI adenocarcinomas remain limited. We profiled 1532 upper GI adenocarcinomas using the clinically validated VENTANA MET (SP44) IHC assay. MET was stratified by (i) 3+ membranous staining fractions (any, ≥ 10%, ≥ 50%) reflecting contemporary ADC eligibility concepts and (ii) H-score (0-300; high ≥ 150). Overall survival analyses and multivariable Cox regression analyses were performed. High MET expression was uncommon (H-score ≥ 150: 2.3%; any 3+: 1.6%; ≥ 10% 3+: 1.3%; ≥ 50% 3+: 1.0%) and enriched in advanced T stage. MET IHC strongly predicted MET amplification (H-score ≥ 150: 63.6% amplified vs. 2.4% in negatives; any 3+: 75.0% vs. 2.6%; all p < 0.001). Any MET 3+ staining was independently associated with inferior overall survival (adjusted HR 2.22, 95% CI 1.29-3.83). Most MET 3+ tumors lacked concurrent HER2 positivity, Claudin-18.2 expression, or dMMR/MSI. In the largest real-world cohort to date, MET overexpression identifies a rare, biologically aggressive subset with poor outcomes. By applying the latest MET-ADC-relevant IHC criteria (including the ≥ 10% 3+ threshold), this study provides clinically translatable prevalence estimates and supports standardized MET testing to inform prospective MET-directed ADC trials in upper GI adenocarcinoma.
MET是一种可作用的受体酪氨酸激酶,MET导向的抗体-药物偶联物(adc)最近已获得FDA批准进入非小细胞肺癌的临床实践,目前正在胃肠道恶性肿瘤中进行评估,患者选择基于不同百分比阈值的MET免疫组织化学(IHC) 3+膜染色。然而,关于上消化道腺癌MET蛋白表达和临床相关adc对齐阈值的可靠真实数据仍然有限。我们使用临床验证的VENTANA MET (SP44)免疫组化法分析了1532例上消化道腺癌。MET通过(i) 3+膜染色分数(任意,≥10%,≥50%)反映当代ADC资格概念和(ii) h评分(0-300;高≥150)分层。进行总生存分析和多变量Cox回归分析。MET高表达不常见(H-score≥150:2.3%;任意3+:1.6%;≥10% 3+:1.3%;≥50% 3+:1.0%),在晚期T期富集。MET IHC强烈预测MET扩增(h评分≥150:扩增63.6%,阴性2.4%;任何3+:75.0%,阴性2.6%
{"title":"MET Expression in Upper Gastrointestinal Adenocarcinoma: Prevalence, Prognostic Impact, and Implications for Anti-MET Antibody-Drug Conjugate Therapy.","authors":"Tillmann Bedau, Thomas Zander, Hans Anton Schlößer, Hakan Alakus, Onur Mustafov, Reinhard Büttner, Christiane Bruns, Alexander Quaas","doi":"10.1002/ijc.70634","DOIUrl":"10.1002/ijc.70634","url":null,"abstract":"<p><p>MET is an actionable receptor tyrosine kinase, and MET-directed antibody-drug conjugates (ADCs) have recently entered clinical practice with FDA approval in non-small cell lung cancer and are now being evaluated across gastrointestinal malignancies, with patient selection based on MET immunohistochemistry (IHC) 3+ membranous staining at varying percentage thresholds. However, robust real-world data on MET protein expression and clinically relevant ADC-aligned thresholds in upper GI adenocarcinomas remain limited. We profiled 1532 upper GI adenocarcinomas using the clinically validated VENTANA MET (SP44) IHC assay. MET was stratified by (i) 3+ membranous staining fractions (any, ≥ 10%, ≥ 50%) reflecting contemporary ADC eligibility concepts and (ii) H-score (0-300; high ≥ 150). Overall survival analyses and multivariable Cox regression analyses were performed. High MET expression was uncommon (H-score ≥ 150: 2.3%; any 3+: 1.6%; ≥ 10% 3+: 1.3%; ≥ 50% 3+: 1.0%) and enriched in advanced T stage. MET IHC strongly predicted MET amplification (H-score ≥ 150: 63.6% amplified vs. 2.4% in negatives; any 3+: 75.0% vs. 2.6%; all p < 0.001). Any MET 3+ staining was independently associated with inferior overall survival (adjusted HR 2.22, 95% CI 1.29-3.83). Most MET 3+ tumors lacked concurrent HER2 positivity, Claudin-18.2 expression, or dMMR/MSI. In the largest real-world cohort to date, MET overexpression identifies a rare, biologically aggressive subset with poor outcomes. By applying the latest MET-ADC-relevant IHC criteria (including the ≥ 10% 3+ threshold), this study provides clinically translatable prevalence estimates and supports standardized MET testing to inform prospective MET-directed ADC trials in upper GI adenocarcinoma.</p>","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":" ","pages":"2606-2618"},"PeriodicalIF":4.9,"publicationDate":"2026-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13595460/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148373990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-11-15Epub Date: 2026-08-12DOI: 10.1002/ijc.70687
Alexander Quaas, Hanna Schiemann, Su Ir Lyu, Thomas Zander, Axel Hillmer, Hans Schlößer, Christiane J Bruns, Reinhard Büttner, Bastian Grothey
Esophageal adenocarcinoma (EAC) exhibits marked male predominance with male-to-female ratios reaching 8.5:1, yet the molecular basis underlying this sex disparity remains poorly characterized. We analyzed 92 EAC specimens using mass spectrometry-based proteomics, comprising 47 female and 45 male tumors from treatment-naïve patients. Differential expression, pathway enrichment, immunohistochemical, and survival analyses were used to identify sex-associated proteomic features and prognostic signatures. Proteomic profiling revealed focal yet biologically meaningful sex differences in EAC. After multiple testing correction, three proteins were differentially expressed: the autosomal protein pregnancy zone protein (PZP), enriched in female tumors, and the Y-chromosome-encoded proteins DDX3Y and RPS4Y1, which were overexpressed in male tumors. At nominal significance, proteins upregulated in female tumors showed marked enrichment of immune-related pathways. Proteins correlated with PZP expression formed a network dominated by complement cascade. Clinically, elevated PZP expression was associated with significantly poorer overall survival specifically in male patients, with no significant association detected in the combined or female-only cohort. Proteome-wide survival analyses further demonstrated distinct sex-specific prognostic landscapes. Our study provides the first comprehensive characterization of sex-associated proteomic differences in EAC. Sex shapes immune-related pathways, prognostic proteomic signatures, and survival associations. PZP emerges as a sex-differential, complement-associated protein with adverse prognostic significance in male patients, highlighting sex as a biologically and clinically relevant variable in EAC.
{"title":"Sex-Specific Proteomic Profiling Identifies Pregnancy Zone Protein as a Complement-Linked Marker of Adverse Prognosis in Esophageal Adenocarcinoma.","authors":"Alexander Quaas, Hanna Schiemann, Su Ir Lyu, Thomas Zander, Axel Hillmer, Hans Schlößer, Christiane J Bruns, Reinhard Büttner, Bastian Grothey","doi":"10.1002/ijc.70687","DOIUrl":"10.1002/ijc.70687","url":null,"abstract":"<p><p>Esophageal adenocarcinoma (EAC) exhibits marked male predominance with male-to-female ratios reaching 8.5:1, yet the molecular basis underlying this sex disparity remains poorly characterized. We analyzed 92 EAC specimens using mass spectrometry-based proteomics, comprising 47 female and 45 male tumors from treatment-naïve patients. Differential expression, pathway enrichment, immunohistochemical, and survival analyses were used to identify sex-associated proteomic features and prognostic signatures. Proteomic profiling revealed focal yet biologically meaningful sex differences in EAC. After multiple testing correction, three proteins were differentially expressed: the autosomal protein pregnancy zone protein (PZP), enriched in female tumors, and the Y-chromosome-encoded proteins DDX3Y and RPS4Y1, which were overexpressed in male tumors. At nominal significance, proteins upregulated in female tumors showed marked enrichment of immune-related pathways. Proteins correlated with PZP expression formed a network dominated by complement cascade. Clinically, elevated PZP expression was associated with significantly poorer overall survival specifically in male patients, with no significant association detected in the combined or female-only cohort. Proteome-wide survival analyses further demonstrated distinct sex-specific prognostic landscapes. Our study provides the first comprehensive characterization of sex-associated proteomic differences in EAC. Sex shapes immune-related pathways, prognostic proteomic signatures, and survival associations. PZP emerges as a sex-differential, complement-associated protein with adverse prognostic significance in male patients, highlighting sex as a biologically and clinically relevant variable in EAC.</p>","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":" ","pages":"2595-2605"},"PeriodicalIF":4.9,"publicationDate":"2026-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13595454/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148710708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-11-01Epub Date: 2026-06-30DOI: 10.1002/ijc.70619
Lucas Penny, Eric Yang Stutheit-Zhao, Birgitta E Michels, Fabian Rosing, Zhen Zhao, Yangqiao Zheng, Jinfeng Zou, Shao Hui Huang, Johnny Carlton, Andrew McPartlin, John R de Almeida, David Goldstein, Andrew Hope, Ali Hosni, John Kim, Fei-Fei Liu, C Jillian Tsai, John N Waldron, Anna Spreafico, Enrique Sanz-Garcia, Lillian L Siu, Tim Waterboer, Geoffrey Liu, Scott V Bratman
The incidence of human papillomavirus-positive (HPV+) oropharyngeal cancer (OPC) has increased rapidly, and HPV early antigen serology has been proposed as a scalable and cost-effective early detection test. HPV seropositivity can precede clinical presentation of OPC by several years, so additional surveillance procedures may be necessary to optimize early cancer detection. The potential for HPV circulating tumor DNA (ctDNA) to confirm a diagnosis of OPC in seropositive individuals is poorly understood. Here, we assess the relationship between HPV serology and HPV ctDNA with disease burden in a large cohort of HPV+ OPC. We analyzed baseline blood samples from 262 patients using a multiplex serology assay and an HPV-targeted deep sequencing assay (HPV-seq), and HPV-seq results were validated by an orthogonal droplet digital PCR assay. Both assays identified HPV16 as the most prevalent genotype (84%), with serology results indicating a total of 4 HPV genotypes and HPV ctDNA results indicating a total of 6 HPV genotypes. HPV ctDNA results demonstrated higher sensitivity and lower cross-reactivity between HPV types compared with HPV serology results. Furthermore, HPV ctDNA but not HPV16 E6 antibody levels were positively associated with disease burden as determined by N-category, overall stage, and by tumor volume (ctDNA vs. volume, r = 0.48 p = 6.4e-12; E6 vs. volume, r = -0.079 p = 0.26). Overall, this is the largest cohort to compare HPV serology and HPV ctDNA results in OPC, and these findings highlight the potential for ctDNA to augment future strategies for blood-based early detection of HPV+ OPC.
{"title":"HPV Serology and Circulating Viral DNA for Detection, Genotyping, and Measurement of Disease Burden in Oropharyngeal Cancer.","authors":"Lucas Penny, Eric Yang Stutheit-Zhao, Birgitta E Michels, Fabian Rosing, Zhen Zhao, Yangqiao Zheng, Jinfeng Zou, Shao Hui Huang, Johnny Carlton, Andrew McPartlin, John R de Almeida, David Goldstein, Andrew Hope, Ali Hosni, John Kim, Fei-Fei Liu, C Jillian Tsai, John N Waldron, Anna Spreafico, Enrique Sanz-Garcia, Lillian L Siu, Tim Waterboer, Geoffrey Liu, Scott V Bratman","doi":"10.1002/ijc.70619","DOIUrl":"10.1002/ijc.70619","url":null,"abstract":"<p><p>The incidence of human papillomavirus-positive (HPV+) oropharyngeal cancer (OPC) has increased rapidly, and HPV early antigen serology has been proposed as a scalable and cost-effective early detection test. HPV seropositivity can precede clinical presentation of OPC by several years, so additional surveillance procedures may be necessary to optimize early cancer detection. The potential for HPV circulating tumor DNA (ctDNA) to confirm a diagnosis of OPC in seropositive individuals is poorly understood. Here, we assess the relationship between HPV serology and HPV ctDNA with disease burden in a large cohort of HPV+ OPC. We analyzed baseline blood samples from 262 patients using a multiplex serology assay and an HPV-targeted deep sequencing assay (HPV-seq), and HPV-seq results were validated by an orthogonal droplet digital PCR assay. Both assays identified HPV16 as the most prevalent genotype (84%), with serology results indicating a total of 4 HPV genotypes and HPV ctDNA results indicating a total of 6 HPV genotypes. HPV ctDNA results demonstrated higher sensitivity and lower cross-reactivity between HPV types compared with HPV serology results. Furthermore, HPV ctDNA but not HPV16 E6 antibody levels were positively associated with disease burden as determined by N-category, overall stage, and by tumor volume (ctDNA vs. volume, r = 0.48 p = 6.4e-12; E6 vs. volume, r = -0.079 p = 0.26). Overall, this is the largest cohort to compare HPV serology and HPV ctDNA results in OPC, and these findings highlight the potential for ctDNA to augment future strategies for blood-based early detection of HPV+ OPC.</p>","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":" ","pages":"2336-2346"},"PeriodicalIF":4.9,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13547982/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148358654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-11-01Epub Date: 2026-07-17DOI: 10.1111/pce.70748
Qiuxin Kan, Guo Chen, Yizhe Jiang, Lin Li, Qing Li
Mitochondrial activity must be tightly coordinated in plants to ensure that energy production is appropriately modulated in response to exogenous and endogenous signals. However, the underlying molecular mechanisms are largely unknown. Here, we investigated this issue by analysing the crosstalk between the nucleus and mitochondria mediated by pentatricopeptide repeat (PPR) proteins, which can regulate the proper function of mitochondrial electron transport chain complexes by affecting C-to-U editing of mitochondrial mRNA. More than 75% of PPR genes in maize (Zea mays) exhibited rhythmic expression, which changed in response to different light conditions. Analysis of mitochondrial RNA editing efficiency throughout the day identified editing sites displaying rhythmic variations, with many sites affecting protein function based on AlphaFold2 prediction. Notably, the peak phase of rhythmic RNA editing lagged behind that of PPR gene expression, suggesting that these two processes are tightly related. We also observed rhythmic expression of PPR genes and rhythmic editing of mitochondrial mRNA in rice (Oryza sativa). These findings suggest that PPR proteins might serve as integrators of environmental signals and transmit these signals to mitochondria by affecting RNA editing.
{"title":"Nuclear PPR Proteins Mediate Rhythmic C-To-U Editing of Mitochondrial RNA in Maize and Rice.","authors":"Qiuxin Kan, Guo Chen, Yizhe Jiang, Lin Li, Qing Li","doi":"10.1111/pce.70748","DOIUrl":"10.1111/pce.70748","url":null,"abstract":"<p><p>Mitochondrial activity must be tightly coordinated in plants to ensure that energy production is appropriately modulated in response to exogenous and endogenous signals. However, the underlying molecular mechanisms are largely unknown. Here, we investigated this issue by analysing the crosstalk between the nucleus and mitochondria mediated by pentatricopeptide repeat (PPR) proteins, which can regulate the proper function of mitochondrial electron transport chain complexes by affecting C-to-U editing of mitochondrial mRNA. More than 75% of PPR genes in maize (Zea mays) exhibited rhythmic expression, which changed in response to different light conditions. Analysis of mitochondrial RNA editing efficiency throughout the day identified editing sites displaying rhythmic variations, with many sites affecting protein function based on AlphaFold2 prediction. Notably, the peak phase of rhythmic RNA editing lagged behind that of PPR gene expression, suggesting that these two processes are tightly related. We also observed rhythmic expression of PPR genes and rhythmic editing of mitochondrial mRNA in rice (Oryza sativa). These findings suggest that PPR proteins might serve as integrators of environmental signals and transmit these signals to mitochondria by affecting RNA editing.</p>","PeriodicalId":222,"journal":{"name":"Plant, Cell & Environment","volume":" ","pages":"8509-8520"},"PeriodicalIF":6.9,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148468029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Angiosperm trees reorient their stems by producing tension wood (TW), a specialised xylem that generates contractile force. TW fibres develop a gelatinous (G) layer rich in cellulose, yet the molecular mechanisms governing G-layer formation remain poorly understood. COBRA-like genes encode glycosylphosphatidylinositol (GPI)-anchored proteins known to regulate cellulose deposition. Here, we functionally characterised PagCOBL5 in hybrid poplar (Populus alba × P. glandulosa) by identifying its upstream regulator and interaction partner. PagCOBL5 was preferentially expressed in mature xylem fibres, with high abundance in TW. Under mechanical stress, cobl5 knockout mutants exhibited impaired negative gravitropism and significantly thinner G-layer-phenotypes that were reversed in PagCOBL5-overexpressing lines. Furthermore, we found that the transcription factors PagLBD21 and PagLBD25 participate in the upstream negative regulation of PagCOBL5 expression, with the lbd21 lbd25/+ mutant exhibiting an enhanced gravitropic response and altered xylem cell differentiation. At the protein level, PagCOBL5 directly interacted with the cellulose synthase subunits PagCESA8b. This interaction positions PagCOBL5 as a key component recruited and spatially organised by the directionally moving cellulose synthase complex (CSC). Together, these results reveal a sophisticated regulatory and protein-interaction framework centred on PagCOBL5, providing pivotal molecular insights into how transcriptional modulation and cellulose synthase complexes coordinate G-layer formation and mechanical force generation during the gravitropic response.
被子植物树通过产生张力木(TW)来重新定位它们的茎,张力木是一种特殊的木质部,可以产生收缩力。TW纤维形成一层富含纤维素的胶状(G)层,然而控制G层形成的分子机制仍然知之甚少。眼镜蛇样基因编码糖基磷脂酰肌醇(GPI)锚定蛋白,已知可调节纤维素沉积。本文通过鉴定杂交杨树(Populus alba × P. glandulosa)中PagCOBL5的上游调控因子和相互作用伙伴,对其进行了功能表征。PagCOBL5在成熟木质部纤维中优先表达,在TW中丰度较高。在机械应力下,cobl5敲除突变体表现出负向重力性受损,g层表型明显变薄,而在过表达pagcobl5的细胞系中,这一现象被逆转。此外,我们发现转录因子PagLBD21和PagLBD25参与了PagCOBL5表达的上游负调控,其中lbd21 lbd25/+突变体表现出增强的向地性反应和木质部细胞分化的改变。在蛋白质水平上,PagCOBL5直接与纤维素合成酶亚基PagCESA8b相互作用。这种相互作用将PagCOBL5定位为定向移动的纤维素合成酶复合体(CSC)招募和空间组织的关键成分。总之,这些结果揭示了以PagCOBL5为中心的复杂调控和蛋白质相互作用框架,为转录调节和纤维素合酶复合物如何协调g层形成和在向地性反应中产生机械力提供了关键的分子见解。
{"title":"PagCOBL5 Integrates Transcriptional and Spatial Cues to Confer G-Layer Deposition in Poplar.","authors":"Xinwei Zhao, Qiao Wang, Liyuan Zhang, Tongfang Yu, Wei Guo","doi":"10.1111/pce.70773","DOIUrl":"10.1111/pce.70773","url":null,"abstract":"<p><p>Angiosperm trees reorient their stems by producing tension wood (TW), a specialised xylem that generates contractile force. TW fibres develop a gelatinous (G) layer rich in cellulose, yet the molecular mechanisms governing G-layer formation remain poorly understood. COBRA-like genes encode glycosylphosphatidylinositol (GPI)-anchored proteins known to regulate cellulose deposition. Here, we functionally characterised PagCOBL5 in hybrid poplar (Populus alba × P. glandulosa) by identifying its upstream regulator and interaction partner. PagCOBL5 was preferentially expressed in mature xylem fibres, with high abundance in TW. Under mechanical stress, cobl5 knockout mutants exhibited impaired negative gravitropism and significantly thinner G-layer-phenotypes that were reversed in PagCOBL5-overexpressing lines. Furthermore, we found that the transcription factors PagLBD21 and PagLBD25 participate in the upstream negative regulation of PagCOBL5 expression, with the lbd21 lbd25/+ mutant exhibiting an enhanced gravitropic response and altered xylem cell differentiation. At the protein level, PagCOBL5 directly interacted with the cellulose synthase subunits PagCESA8b. This interaction positions PagCOBL5 as a key component recruited and spatially organised by the directionally moving cellulose synthase complex (CSC). Together, these results reveal a sophisticated regulatory and protein-interaction framework centred on PagCOBL5, providing pivotal molecular insights into how transcriptional modulation and cellulose synthase complexes coordinate G-layer formation and mechanical force generation during the gravitropic response.</p>","PeriodicalId":222,"journal":{"name":"Plant, Cell & Environment","volume":" ","pages":"8898-8911"},"PeriodicalIF":6.9,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148663093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-11-01Epub Date: 2026-07-30DOI: 10.1111/pce.70776
Quan Zuo, Qian Sun, Pei-Yi Wang, Yi-Tong Song, Fang-Xu Han, Xi Chen, Feng-Yi Li, Wen-Cheng Shi, Shi-Hui Niu
Conifers exhibit distinct age-related transitions in wood development, yet the molecular mechanisms governing these changes remain poorly characterized. Here, we integrate multi-omics and functional analyses to unravel a transcriptional regulatory network underlying age-related wood formation in Chinese pine (Pinus tabuliformis). Cross-sectional and Raman microspectroscopy analyses revealed age-dependent enhancement of lignification and carbohydrate deposition in secondary xylem, coinciding with increased pith proportion. Temporal transcriptome profiling identified PtARN (AGE-RELATED NAC TRANSCRIPTION FACTOR) as a key age-correlated regulator, whose expression is directly activated by the conserved age timer PtDAL1 through promoter binding. We conducted a genome-wide identification of secondary cell wall biosynthesis pathway genes in P. tabuliformis, and genome-wide DNA affinity purification analysis uncovered that PtARN direct binding to promoters of 189 secondary cell wall biosynthesis genes. Strikingly, PtARN represses PtMYB162, a lignin biosynthesis suppressor, forming a regulatory cascade to fine-tune lignification. Collectively, our work establishes PtARN as a master regulator orchestrating age-dependent secondary cell wall deposition and lignification in the secondary xylem of Chinese pine, and delineates a previously uncharacterized PtDAL1-PtARN-mediated molecular regulatory network in P. tabuliformis. These findings significantly advance our understanding of the molecular regulatory network underlying wood formation in conifers, and bridging developmental timing with cell wall remodelling, and provide a robust framework for conifer-specific wood formation studies.
针叶树在木材发育过程中表现出明显的年龄相关转变,但控制这些变化的分子机制仍不清楚。在这里,我们整合了多组学和功能分析来揭示油松(Pinus tabuliformis)年龄相关木材形成的转录调控网络。横截面和拉曼显微光谱分析显示,次生木质部木质化和碳水化合物沉积的增强与年龄相关,与髓比例的增加相一致。时间转录组分析发现PtARN (age- related NAC TRANSCRIPTION FACTOR)是一个关键的年龄相关调节因子,其表达是由保守的年龄计时器PtDAL1通过启动子结合直接激活的。我们对油状假单胞菌的次生细胞壁生物合成途径基因进行了全基因组鉴定,全基因组DNA亲和纯化分析发现,PtARN直接结合189个次生细胞壁生物合成基因的启动子。引人注目的是,PtARN抑制木质素生物合成抑制因子PtMYB162,形成调控级联以微调木质素化。总之,我们的工作确定了PtARN是协调油松次生木质部年龄依赖性次生细胞壁沉积和木质素化的主要调节剂,并描绘了油松中ptdal1 -PtARN介导的分子调节网络。这些发现极大地促进了我们对针叶树木材形成的分子调控网络的理解,并将发育时间与细胞壁重塑联系起来,为针叶树木材形成的研究提供了一个强有力的框架。
{"title":"The NAC Transcription Factor PtARN Governs Age-Related Wood Formation via a PtDAL1-PtARN Regulatory Cascade in Chinese Pine.","authors":"Quan Zuo, Qian Sun, Pei-Yi Wang, Yi-Tong Song, Fang-Xu Han, Xi Chen, Feng-Yi Li, Wen-Cheng Shi, Shi-Hui Niu","doi":"10.1111/pce.70776","DOIUrl":"10.1111/pce.70776","url":null,"abstract":"<p><p>Conifers exhibit distinct age-related transitions in wood development, yet the molecular mechanisms governing these changes remain poorly characterized. Here, we integrate multi-omics and functional analyses to unravel a transcriptional regulatory network underlying age-related wood formation in Chinese pine (Pinus tabuliformis). Cross-sectional and Raman microspectroscopy analyses revealed age-dependent enhancement of lignification and carbohydrate deposition in secondary xylem, coinciding with increased pith proportion. Temporal transcriptome profiling identified PtARN (AGE-RELATED NAC TRANSCRIPTION FACTOR) as a key age-correlated regulator, whose expression is directly activated by the conserved age timer PtDAL1 through promoter binding. We conducted a genome-wide identification of secondary cell wall biosynthesis pathway genes in P. tabuliformis, and genome-wide DNA affinity purification analysis uncovered that PtARN direct binding to promoters of 189 secondary cell wall biosynthesis genes. Strikingly, PtARN represses PtMYB162, a lignin biosynthesis suppressor, forming a regulatory cascade to fine-tune lignification. Collectively, our work establishes PtARN as a master regulator orchestrating age-dependent secondary cell wall deposition and lignification in the secondary xylem of Chinese pine, and delineates a previously uncharacterized PtDAL1-PtARN-mediated molecular regulatory network in P. tabuliformis. These findings significantly advance our understanding of the molecular regulatory network underlying wood formation in conifers, and bridging developmental timing with cell wall remodelling, and provide a robust framework for conifer-specific wood formation studies.</p>","PeriodicalId":222,"journal":{"name":"Plant, Cell & Environment","volume":" ","pages":"8799-8814"},"PeriodicalIF":6.9,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148617696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}